From: Future developments in biosensors for field-ready Zika virus diagnostics
Assay technique | Detection mode | Target | Sample matrix | Range of detection | Limit of detection | Sample volume | Assay time | Cost per assay | Ref. |
---|---|---|---|---|---|---|---|---|---|
Immunoassay | Impedimetry | NS1 (flaviviruses) | PBS Serum | 10-2000 ng/mL 10-1000 ng/mL | 3 ng/mL 30 ng/mL | 40 μL | 30 min | unspecified | [61] |
Capacitance | NS1 (flaviviruses) | PBS Serum | 5-1000Â ng/mL 5-1000Â ng/mL | 0.2Â ng/mL 0.5Â ng/mL | |||||
Immunoassay | Chemiluminescence | E protein (ZIKV) | PBS Urine, plasma | 10-105 PFU/mL 10-104 PFU/mL | 10 PFU/mL 10 PFU/mL | 100 μL | ~2 h | unspecified | [68] |
LAMP | AC susceptometry | NS5 oligonucleotide (ZIKV) | Unspecified Serum | 1-103 aM 1-104 aM | 1 aM 1 aM | 40 μL | <30 min | unspecified | [41] |
NASBA-CRISPR | Colorimetry | RNA (ZIKV) | Serum | 3 fM - 30 pM | 1 fM | 300 μL | ~3 h | $0.10-$1 | [39] |
RT-LAMP | Colorimetry | E protein RNA (ZIKV) | Saliva | 50-5 × 104 PFU/mL | 50-100 PFU/mL | 65 μL | 40 min | ~$2 | [40] |
RT-SIBA | Fluorescence | RNA (ZIKV) | Lysis buffer | 5 × 103-5 × 106 copies/mL | 5000 copies/mL | 2 μL | <30 min | unspecified | [42] |